Clinical Trial Update: Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

View source ↗

Summary

A clinical trial update investigates longitudinal changes in donor-derived cell-free DNA with tocilizumab treatment for chronic antibody-mediated rejection in k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection
• Kidney Transplant Rejection

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Rejection Chronic Renal, Kidney Transplant Rejection | Status: ACTIVE_NOT_RECRUITING